Background: While the various antitumororal activities of adiponectin as an adipocyte-derived hormone well studied, it is speculated that there is a crosstalk between adiponectin and esterogen receptor (ER) signaling. To test this hypothesis we evaluate the possible correlation between serum level of adiponectin with two estrogen receptors (ERα and ERβ) gene expression in breast cancer patients. Methods: In this case-control study, 70 women with breast cancer participated with different grades of obesity (36 none obese, BMI < 25 kg/m 2 and 34 obese, BMI ≥ 25 kg/m 2 ).The mean age of Participants was 44.53 yr ± 1.79 yr (21 yr -70 yr) .Serum level of adiponectin determined by ELISA. Following quantitative expression of estrogen receptors mRNA in tumor tissues was evaluated by Real-time PCR. Results: We find a significant reverse correlation between serum level of Adiponectin and ERα mRNA (r = -0.229, n = 64, p = 0.035) but no correlation was between adiponectin and ERβ in samples (p = 0.228). The lower adiponectin multiplied the odds of having higher ERα mRNA level by a factor of OR = 4.33, 1.28 -14.6, 95% confidence interval (CI) as compared with those that displayed a moderate or higher serum level of adiponectin (>7.02 ng/ml). The same odds for next estrogen receptor, ERβ, was not greater than unity (OR = 0.31, 0.06 -1.56, 95% CI). Conclusion: According to the obtained results, it is speculated that as adiponectin can affect ERs gene expression, so affecting the steroid receptor signaling can be proposed as a new underling mechanism of action for this adipokine in breast cancer pathogenesis especially in obese ones.
Introduction
Breast cancer is the most common neoplasm in women [1] . Far now many studies revealed the connection between obesity and breast cancer risk [2] [3] [4] [5] . One explanation for this association, is elevated circulating estrogen levels resulting from peripheral aromatization of androgens in the adipose tissue in obese postmenopausal women that can act as a mitogen and cause to development and progression of hormone dependant cancers [6] . Estrogen exert its effect in tissues through two receptors: Estrogen receptor α (ERα) and estrogen receptor β (ERβ).The effect of these two receptors can be opposite. ERα has mitogennic properties and cause to proliferation of mammary cells, while ERβ exerts anti proliferative activities and can oppose and regulate ERα gene expression [7] [8] [9] . In normal breast ERβ is the dominant estrogen receptor while, in cancerous breast the ratio of ERα/ERβ increases and the expression of ERα gene is dominant [10, 11] . Apart from role of estrogen and its receptors in pathogenesis of breast cancer, it is now recognized that the white adipose tissue (WAT) produces a variety of bioactive peptides, collectively termed "adipokines" [12, 13] . Alteration of WAT mass in obesity, affects the production of most adipose secreted factors. Among the known adipocye-derived hormones, Adiponectin is unique from others [12, 14] . While excess adipose tissue in obese subjects increase production of most of adipokines such as leptin, obese subjects have a lower serum level of adiponectin in comparison to their lean counterparts, moreover weigh loss can increase serum level of adiponectin [3, 15] . Many in vitro studies revealed the anti-tumoral effects of this adipocytokine such as its anti-angiogenic, pro apoptotic, anti inflammatory and anti prolifrative activities that propose it as a potent tumor suppressor gene [16, 17] . Recently it is proposed that there may be a crosstalk between this adipokine and estrogen receptor signaling [11, 17] , so the aim of this study was to determine the possible connection between serum level of adiponectin and ERα and ERβ gene expression in breast cancer tissues.
Materials and Methods

Patients and Samples (Tissue and Serum)
This work was a discriptional and cross sectional study. All samples were obtained from 70 women who underwent biopsy or mastectomy surgical operation at Tabriz Emam Reza Hospital from July 2009 till May 2010. The whole project has been carried out in Tabriz Drug Applied Research Center. The samples were examined histologically for the presence of tumor cells by a Pathologist. The patients met the following criteria: primary unilateral non metastatic breast carcinoma for which complete clinical, histological and biological data were available; and no radiotherapy or chemotherapy before surgery.
Analysis of Serum Level of Adiponectin
Plasma concentrations of adiponectin determined by means of commercially available quantitative sandwich enzymelinked immunosorbant assay (ELISA) kits (Adiponectin-ELISA E09, Germany). The sensitivity of this assay was <0.6 ng/ml. masked split specimens included within each batch were used to calculate the coefficient of variation (CV) within and between batches: the intra-and interassay CVs of this adipokine was below 6.7% and 4.7% for adiponectin, respectively.
Preparation of Total RNA
Approximately 100 mg of tissue for RNA extraction by means of RNAX reagents previously described by jahanban et al. [10] . The quality of RNA samples ensured by electrophoresis in an agarose gel followed by ethidium bromide staining, where the 18S and 28S RNA bands could be visualized under UV light. Quantification of RNA was performed in duplicate by spectrophometry at 260 nm.
cDNA Synthesis
RNA was converted to cDNA after treating with DNase I. Reverse transcription of RNA was done in a final volume of 20 μl by using of cDNA first strand synthesis kit (Fermentase) random hexamere and 1 μg of total RNA. The samples were incubated at 65˚C for 10 min and 42˚C for 60 min, and reverse transcriptase was inactivated by heating at 70˚C for 5 min and cooling at 4˚C for 5 min.
Real-Time RT-PCR
Principle: Reactions are characterized by detection of cycling amplification of the PCR product, rather than the amount of PCR product accumulated after a fixed number of cycles. If the amount of the target molecule was larger, the earlier a significant increase in fluorescence is observed. The parameter Ct (threshold cycle) is defined as the cycle number at which the fluorescence generated by cleavage of the probe passes a fixed threshold above baseline. The details of qRT-PCR assay for determination of estrogen receptors mRNA level has been described in our previous work [10] .
Statistical Analysis
T student test used to analysis the difference in serum level of adiponectin between obese and non-obese subjects. Pearson correlation coefficients were used to examine cross-sectional relationships between steroid hormone receptors expression and serum level of adionectin among subjects. All statistical analysis was conducted using SPSS statistical software (version 16). p < 0.05 were considered statistically significant.
Results
In this case-control study, 70 women with breast cancer participated with different grades of obesity (36 none obese, BMI < 25 kg/m 2 and 34 obese, BMI ≥ 25 kg/m 2 ). The mean age of Participants was 44.53 yr ± 1.79 yr (ranged from 21 -70 years old) and half of them were under 44 years old at the time of enrollment. Patients with previous history of radiotherapy or chemotherapy Excluded from this study our results indicated that there was a relationship between family breast-cancer history and obesity in breast cancer patients (p = 0.01). Baseline characteristics are summarized in Table 1 .
Determination of Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Tissues
The result of quantification of estrogen receptors gene expression described thoroughly in our previous work (10) . According to the ΔCT values, the mean mRNA level of ERα was 11.73 ± 0.41 in non obese cases vs 7.40 ± 0.46 in obese ones and the mean mRNA level of ERβ was 8.01 ± 0.53 in non obese individuals vs 14.15 ± 0.64 in obese subjects (The higher ΔCT values was an indication to lower mRNA level). Moreover, we find that obese subjects expressed a higher level of ERα in comparison to non-obese subjects and the difference in ERα mRNA level between these two groups of patients was significant (p < 0.001).In case of ERβ, the expression of ERβ was lower in obese ones and the difference in ERβ mRNAlevel between two groups was statistically significant (p < 0.001).
Correlation between Steroid Receptors and Serum Level of Adiponectin in Breast Cancer Patients
We analyzed serum level of adiponectin in 70 breast cancer subjects. The mean serum level of adiponectin was 9.54 ng/ml ± 0.44 ng/ml. Obese subjects has a lower adiponectin in comparison to their lean counterparts (8.33 ± 0.48 vs. 10.61 ± 0.66) (Figure 1) .One tailed spearman coefficient test show that there was a significant reverse correlation between serum level of Adiponectin and ERα mRNA level(r = -0.229, n = 64, p = 0.035) but no correlation was between adiponectin and ERβ in samples (p = 0.285) (Figure 2) . We next considered the effect of serum level of adiponectin on the receptor mRNA status. The most relevant results from Chi-square test, revealed a significant relation between serum level of adiponectin and ERα gene expression (p = 0.02). 
Discussion
According to the results of our previous works [10, 11] and the findings of this study we propose that affecting the estrogen receptor status is another mechanism of action of adiponectin that can affect prognosis of disease in breast cancer patients (see Figure 3) . Far now many studied focused on antiproliferative and apoptotic effects of adiopnection on different breast cancer cell lines (16 -18) (see Table 1 ). In one study by Marie-Noelle Dieudonne and his coworkers show that adiponectin represses c-myc and cyclin D1 mRNA expressions which strongly suggests that the inhibitory effect of this hormone on MCF-7 cell growth is due to a direct blockade of G1-S phase cell cycle progression (19). In addition, they observed that a simultaneous exposure to adiponectin and 17b-estradiol leads to suppress the mitogenic effect of 17b-estradiol on MCF-7 cells. Georg H. Pfeiler investigated adiponectin effects on human MCF-7, MDA 231 and T47D breast cancer cell lines. Like as Dieudonne, they demonstrate that E2 significantly reduces the AdipoR1 (adiponectin receptor) expression in ERα-positive MCF-7 breast can- Studies show that ERβ is dominant ER in normal breast and so ER signaling is normal is cases with normal serum level of adiponectin. B: At the other hand, obese cases frequently represent decreased serum level of this adipocytokine and display a higher expression of ERα mRNA as we observed in our study [11] , from previous studies we know that mitogenic effects attributed to over expression of ERα and this receptor is the dominant ER in cancerous breast where the ratio of ERα/ERβ increases and disrupt normal ER signaling.
cer cells. It is tempting to speculate that the E2-triggered down-regulation of AdipoR1 may be a signaling crosstalk directly affecting breast cancer risk (16 Treeck and his colleagues postulated that there is a cross talk between adiponectin and ER signaling. In their study on MCF-10A cells, adiponectin triggered a significant increase of ERβ2 and ERβ5 mRNA levels [17] . The antimitogeneic activites of ERβ attributed to ERβ2 (also known as ERβcx) [9] . As ERa is known to mediate tumour-promoting effects of 17-b estradiol [18], they suggest that adiponectin-triggered increase of ERβ isoform expression might be one important molecular mechanism underlying the protective effects of this adipocytokine [17] . We find out that lower serum level of adiponectin multiplied the odds of having higher ERα mRNA level by a factor of OR = 4.33, 1.28 -14.6, 95% confidence interval (CI) as compared with those that displayed a moderate or higher serum level of adiponectin. In this case we confirm findings of Pfeiler 
Conclusion
According to the obtained results, as adiponectin can affect ERs gene expression, so affecting the estrogen receptor signaling can be proposed as a new underling mechanism of action for this adipokine in breast cancer pathogenesis specially in obese subjects. In this study we were not able to show whether ER mRNA level could downregulate the serum level of adiponectin or not, so further studies require to clarify the possible effect. We speculate that serum level of adiponectin can affect estrogen receptors gene expression and so the pattern of ER positive or negattiveness and this in turn could affect the prognosis of disease in obese breast cancer subjects.
